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Abstract
Background: Excessive fat deposition is one of the largest problems faced by salmon aquaculture industries,
leading to production losses due to high volume of adipose tissue offal. In addition, increased lipid accumulation
may impose considerable stress on adipocytes leading to adipocyte activation and production and secretion of
inflammatory mediators, as observed in mammals.
Results: Microarray and qPCR analyses were performed to follow transcriptome changes during adipogenesis in
the primary culture of adipose stromo-vascular fraction (aSVF) of Atlantic salmon. Cellular heterogeneity decreased
by confluence as evidenced by the down-regulation of markers of osteo/chondrogenic, myogenic, immune and
vasculature lineages. Transgelin (TAGLN), a marker of the multipotent pericyte, was prominently expressed around
confluence while adipogenic PPARg was up-regulated already in subconfluent cells. Proliferative activity and
subsequent cell cycle arrest were reflected in the fluctuations of pro- and anti-mitotic regulators. Marked regulation
of genes involved in lipid and glucose metabolism and pathways producing NADPH and glycerol-3-phosphate
(G3P) was seen during the terminal differentiation, also characterised by diverse stress responses. Activation of the
glutathione and thioredoxin antioxidant systems and changes in the iron metabolism suggested the need for
protection against oxidative stress. Signs of endoplasmic reticulum (ER) stress and unfolded protein response (UPR)
occured in parallel with the increased lipid droplet (LD) formation and production of secretory proteins (adipsin,
visfatin). The UPR markers XBP1 and ATF6 were induced together with genes involved in ubiquitin-proteasome and
lysosomal proteolysis. Concurrently, translation was suppressed as evidenced by the down-regulation of genes
encoding elongation factors and components of the ribosomal machinery. Notably, expression changes of a panel
of genes that belong to different immune pathways were seen throughout adipogenesis. The induction of AP1
(Jun, Fos), which is a master regulator of stress responses, culminated by the end of adipogenesis, concurrent with
the maximal observed lipid deposition.
Conclusions: Our data point to an intimate relationship between metabolic regulation and immune responses in
white adipocytes of a cold-blooded vertebrate. Stress imposed on adipocytes by LD formation and expansion is
prominently reflected in the ER compartment and the activated UPR response could have an important role at
visceral obesity in fish.
Background
Feeds used in modern Atlantic salmon aquaculture con-
tain large amounts of lipids, which provide rapid
growth, reduce environmental load from farms, but
increase visceral fat deposition [1]. Very little is,
however, known about the factors regulating develop-
ment and functions of adipose tissue in fish, and
whether increased fat deposition may lead to health pro-
blems. Previously regarded principally as energy storage,
white adipose tissue (WAT) in mammals is now recog-
nized as a highly active endocrine tissue producing
numerous secretory proteins, including adipokines, a
suite of small signalling proteins specifically produced in
WAT [2,3]. Under normal conditions, adipocytes are
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gical processes but at obesity increased production of
cytokines and adipokines lead to the chronic low-grade
inflammatory state. The extent of conservation of endo-
crine WAT functions in the cold-blooded vertebrate,
including its capacity to influence systemic inflammatory
responses and development of life style related disorders
has not been studied until now.
In salmonid fish, precursor cells differentiate into adi-
pocytes continuously [4], however, the exact origin of
preadipocytes is not known. In mammals, development
of white adipocytes is thought to begin with progenitor
cells from the perivascular compartment (pericytes) in
WAT, characterised by expression of smooth muscle
actin 22a, also known as transgelin (TAGLN), and other
vascular markers. Isolated pericytes differentiate into
mesenchymal stem cells (MSCs), which in turn, give rise
to various cell types including osteoblasts, chondrocytes,
smooth muscle cells, fibroblasts, macrophages and adi-
pocytes [5-9]. Mammalian adipose stromal-vascular frac-
tion (aSVF) harbours a population of progenitor cells
that is also capable to differentiate ex vivo into cells and
tissues of mesodermal origin, thus suggesting their peri-
vascular origin. Atlantic salmon WAT contains a large
number of fibroblast-like precursor cells that can differ-
entiate to mature adipocytes in vitro [10,11], however,
their stem cell features have not been characterized yet.
In mammals, adipogenesis includes three distinct
stages. Following active proliferation and the phase of
determination, cells reach confluence, followed by hor-
monal induction and terminal differentiation. Re-entry
into the cell cycle of growth-arrested cells at confluence
involves several rounds of proliferation, referred to as
mitotic clonal expansion. Secondary growth arrest and
induction of the transcription factors CCAAT-enhancer-
binding protein (C/EBP) a and peroxisome proliferator-
activated receptor (PPAR) g mark the end of the mitotic
clonal expansion phase and entry into terminal differen-
tiation with transcriptional activation of genes defining
the mature adipocyte phenotype.
The few performed studies indicate that adipogenesis
in fish bears many resemblances to that of terrestrial
vertebrates [10-12], though there certainly exist as yet
undiscovered species-specific differences. Atlantic sal-
mon precursor cells take longer than mammalian to
acquire the mature adipocyte phenotype in culture, due
to low incubating temperature, typical of salmonid fish
habitat. Further, mammalian cells are able to produce
lipid droplets (LDs) from glucose alone, while salmon
preadipocytes require lipids in order to achieve the
mature phenotype [10]. Hence it is to be expected that
white adipocytes and their precursors in a cold-blooded
vertebrate may have both evolutionarily conserved and
specific features.
The aSVF primary culture enabled investigation of
early events involved in the adipogenic determination as
well as processes characteristic of the later terminal dif-
ferentiation phase. Particular emphasis was placed on
genes governing nutrient metabolism and stress and
inflammatory responses.
Results
Cell culture characterization
A short summary of adipocyte development and cultiva-
tion conditions is presented in Fig. 1. In the subconflu-
ent stage during the first seven days of culture, aSVF
cells had the highest proliferative activity (Fig. 2A).
Approximately at day 7, cells reached the confluent
stage. Two-day adipogenic hormonal induction was
applied at that time point. This was followed by the
terminal differentiation stage during which cells
acquired a more rounded shape. Morphological changes
observed by electron microscopy images at days 15 and
30 were characteristic of the terminally differentiating
phenotype of adipocytes, including a relatively low mito-
chondrial number, large size of LD and the nucleus
located between LDs and cell membrane (Fig. 3A, B).
Oil red O staining also showed a high degree of lipid
accumulation in mature adipocytes at day 30 (Fig. 4A).
A steady decrease in the extracellular superoxide dismu-
tase (SOD) activity was observed from day 1 to day 30
(Fig. 4B).
Subconfluence (days 1 and 4)
Microarray analyses of aSVF in the first days of culture,
revealed concurrent expression of genes characteristic of
MSCs, immune cells and cells of perivascular origin
(Fig. 5). Platelet-derived growth factor A (PDGFA) is a
major regulator of proliferation and migration of mam-
malian adipose-derived MSCs [13]. Glomulin is essential
for normal development of the vasculature while the
lymphatic vessel endothelial hyaluronan receptor 1
(LYVE1) is a marker of lymph vessels and endothelial
cells in mammals. Chemokine receptor 4 (CXCR4) and
other chemokine/cytokine receptors are involved in cell
mobilisation and retention in several populations of
MSCs and in immune cells [14-16]. We have selected
eight co-expressed genes encoding proteins involved in
nucleotide metabolism, DNA replication and regulation
of cell cycle and their averaged profile, due to their
involvement in the similar cellular functions, was shown
in Fig. 2B. The lowest expression of genes from this
category was at day 1 (also see Fig. 5). The subsequent
increase was in concordance with the results of prolifer-
ating cell nuclear antigen (PCNA) assay that revealed
the highest proliferation rate at day 4 (Fig. 2A). In paral-
lel, microarray analyses showed a decreased expression
of non-adipogenic cell markers. These genes had high
levels at day 1 (Fig. 5). Tumour necrosis factor (TNF) a,
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lator of adipocyte differentiation in terrestrial verte-
brates, was up-regulated before confluence as well as a
panel of TNF-related genes and receptors (Fig. 5 and 6).
We observed up-regulation of PPARg already at day 4
(Fig. 7). This is the master regulator that co-ordinately
activates transcription of adipocyte-specific genes
[17,18].
Confluence (day 7) and hormonal induction (day 9)
Cells reached confluence at day 7. Up-regulation of reti-
noblastoma-like protein 1 (RBL1) and p53-like protein
(Fig. 5) was in concordance with the temporary cell
cycle arrest at G0/G1, which is commonly observed at
this stage in most mammalian cell lines. After stimula-
tion with hormones, cells re-enter the cell cycle and
undergo mitotic clonal expansion before ultimate exit
from the cell cycle. At day 9, expression of RBL1 and
p53-like protein decreased while cyclins E1 and B2 were
stimulated. Two days after addition of the differentiation
media, cells changed to a more rounded shape. This
coincided with the up-regulation of a suite of motor
contractile proteins (Fig. 5). Interestingly, microarray
showed elevated expression of TAGLN at day 7 and day
9. TAGLN is a marker of pericytes, smooth muscle-like
cells surrounding vasculature, that are closely related to
the MSCs and fibroblasts [19]. Positive and negative reg-
ulators of myogenic differentiation showed opposite
changes: decrease in myogenic factor D (MyoD) and
increase in bone morphogenic protein 4 (BMP4) (Fig.7).
We also observed up-regulation of several genes for Ca
2
+ binding proteins (Fig. 5). Calcium is involved in the
control of the whole adipogenic process, from multipo-
tent stem cells to adipocytes [20,21]. Increases in cyto-
plasmic calcium during this phase inhibit adipogenesis
[21-24]. Days 7 and 9 were marked by the expression
changes of C/EBPs. The early adipogenic marker C/
EBPb, was up-regulated until confluence, whereas tran-
sient induction of C/EBPδ and consistent increase of C/
EBPa were observed after the addition of hormones at
day 9 (Fig. 7). Overall, C/EBPb and C/EBPδ work
sequentially and predate the expression of C/EBPa [12].
We observed different expression changes in a number
of genes encoding chemokines and cytokines. The leu-
kocyte cell-derived chemotaxin 2 (LECT2) was re-acti-
vated at day 9 and remained up-regulated until the end
of the study period (Fig. 6). LECT2 is a potent neutro-
phil chemoattractant, which also affects development of
 D1 D4   D5   D6  D7 D9   D10    D11   D12                  D15            D20           D23             D30 
 Medium=                                      Medium             Medium 
FBS (10%)                                 
L-15                                              +Insulin             +lipid mix 
Antibiotics    
L-glutamin    
 +Dex 
 +IBMX 
                  Subconfluent        Confluent       Terminal differentiation 
       Hormonal induction 
 +Biotin 
 +Pantoten 
 +T3 
  FBS..........Fetal Bovine Serum 
  Dex.......... Dexametasone 
    IBMX....... Isobutylmethylxanthine  
T3.............Triiodothyronine  
D1,D4,D7,D9,D15,D30 = Microarray & qPCR 
D5,D6,D10,D11,D12,D20,D23,D30 = qPCR  
Figure 1 Summary of procedures and the key stages.
Figure 2 Cell division, DNA replication and nucleotide
metabolism. A: cell proliferation was assessed by
immunocytochemical detection of proliferating cell nuclear antigen
(PCNA). Data (labeling index) are shown as mean ± SEM (n = 5).
Different letters indicate significant differences (p ≤ 0.05). B:
expression changes (mean log-ER ± SE) of eight genes (Cdc45, cell
division control protein 42 homolog, anti-silencing function 1B,
ribonucleoside-diphosphate reductase large subunit, cold inducible
RNA binding protein-1 and 2, chromosome segregation 1-like
protein, chromosome-associated kinesin KIF4A) analyzed with
microarrays.
Todorčević et al. BMC Genomics 2010, 11:39
http://www.biomedcentral.com/1471-2164/11/39
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and related genes were down-regulated (Fig. 5 and 6).
Terminal differentiation and the late phase of white
adipocyte maturation (days 12-30)
The increase in intracellular lipid levels measured by Oil
Red O (Fig. 4A) was in line with the up-regulation of
genes for several proteins of lipid metabolism (Fig. 5),
including lipoprotein lipase (LPL) (Fig. 7). The expres-
sion of fatty acid synthase (FAS) was highest from day
15 to day 30 (Fig. 7) in agreement with the profile of
FAS observed in murine adipocytes [27]. Metabolic
alterations were also supported by the regulation of key
genes from major carbohydrate pathways (Fig. 8). Glu-
cose-6-phosphate dehydrogenase (G6PD) and 6-
phosphogluconate dehydrogenase (PGD) from the oxi-
dative pentose phosphate pathway (PPP) were up-regu-
lated from day 12 to the end of adipogenic
differentiation indicating increased need for NADPH
that is required for TAG biosynthesis. To synthesise
nucleotides, cells need large amounts of ribose-5-phos-
phate (R5P). The PPP uses glucose to provide R5P and
NADPH, however, the output can be modified accord-
ing to the cells’ current needs, towards the production
of either one of the products. The increase of phospho-
fructokinase (PFK) and pyruvate kinase (PK) expression
from day 15 could be an evidence for the importance of
glycolysis in TAG-accumulating adipocytes. In addition
to glycolysis and contrary to what was earlier believed,
Figure 3 Atlantic salmon aSVF primary cell culture. A, B: Electron micrographs of representative salmon adipocytes day 15 (A) and day 30
(B). Three weeks after induction of differentiation (day 30), a large portion of cytoplasmic space was filled with LDs, the number mitochondria
was reduced and the nuclei were located between LDs and cell membranes. Bars: 5 μm. Arrows points to mitochondria and arrowheads to lipid
droplets
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(glyceroneogenesis) to produce glycerol-3-phosphate
(G3P) needed for TAG synthesis [28,29]. Two key gly-
ceroneogenic enzymes, cytoplasmic malate dehydrogen-
ase (MDHC) and cytosolic phosphoenolpyruvate
carboxykinase (PEPCKC) were also up-regulated during
terminal differentiation. These changes did not necessa-
rily mean a switch to anaerobic metabolism. Microarray
analyses revealed a decrease of hypoxia inducible factor
(HIF1a) while the negative regulator of HIF1a (HIF
prolyl hydroxylase) was induced (Fig. 5).
Day 15 was marked with the expression changes of
genes involved in differentiation and cell cycle. Increase
was observed in the anti-osteogenic [30] growth arrest
specific protein 6 (GAS6) and adipogenic markers adip-
sin and visfatin (Fig. 5). The up-regulations of RBL1,
p53-like protein and growth arrest and DNA-damage-
inducible (GADD45) g were in concordance with the
marked attenuation of cell proliferation. Interestingly,
many immune-related genes exhibited sustained up-reg-
ulations, which began shortly before or at the onset of
terminal differentiation (Fig. 6). Programmed death
ligand 1 (PD-L1) is involved in the blockage of cell cycle
in T-cells [31]. The up-regulation of decoy receptor
interleukin (IL) 13 receptor alpha 2 (IL13Ra2) implies
suppression of the anti-inflammatory IL4/IL13 axis [32].
Janus kinase 1 (JAK1) and 5-lipoxygenase activating pro-
tein (FLAP) play pivotal roles in respectively, cytokine
receptor signalling and biosynthesis of eicosanoids (lipid
mediators of inflammation). Galectins (Fig. 5) are carbo-
hydrate binding proteins involved in various immune
processes [33]. Notably, expression of a panel of
immune genes decreased by day 30.
The most noticeable aspect of the last stage of adipo-
genesis was co-ordinated activation of genes involved in
various stress responses. Several components of the acti-
vator protein complex 1 (AP1) (c-Fos, c-Jun, JunB1,
JunB2, and JunD), which co-ordinates responses to
pathogens and stressors, showed highest expression
levels at day 30 (Fig. 5). The observed gene expression
changes clearly revealed the endoplasmic reticulum (ER)
stress in our culture at this stage. The up-regulated oxi-
dant stress-activated serine/threonine kinase 25 (YSK1,
Fig. 5) is a Golgi complex-associated regulator of trans-
port of proteins and lipids to plasma membrane [34].
The A-kinase anchor protein 9 (AKAP9) is an essential
mediator in lipolytic pathways and is necessary for the
maintenance of Golgi structure through interactions
with signalling proteins, including the protein kinase N
(PKN1); both AKAP9 and PKN1 showed strong down-
regulation at day 15 (Fig. 5). The ER stress response
involves a set of mechanisms referred to as unfolded
protein response (UPR) [35]. The classical UPR markers
X-box-binding protein 1 (XBP1) and activating tran-
scription factor 6 (ATF6) were up-regulated during the
lipid-loading phase of adipogenesis (Fig. 9). Our findings
point to the increased responses to oxidative stress with
time. The glutathione peroxidases (GPXs) (Fig. 5 and 9),
which are sensitive to lipid mediated peroxidation [36],
were similarly induced and a suite of genes coding for
proteins of glutathione metabolism also had high levels,
at the time when cells engaged in increased LD forma-
tion and expansion. The thioredoxin (TXN) antioxidant
system is also involved in the regulation of intracellular
ROS [37]. The production of ROS is catalyzed with iron
and hem, therefore, the up-regulation of ferritin (the
intracellular iron storage protein), and two key enzymes
in the metabolism of hem, aminolevulinate δ synthetase
a n dh e m eo x y g e n a s e2( H M O X 2 )s u g g e s tt h ei n d u c t i o n
of mechanisms that protect against oxidative stress at
day 30.
The massive down-regulation of components of the
translational machinery and translation initiation factors
suggested reduction of ribosomal biogenesis and
attenuation of protein translation while the highest
expression level of 18S at day 15 suggested profound
changes in the composition of ribosomes during term-
inal differentiation (Fig. 5, 9 and 10). Averaged expres-
sion profiles of thirty five highly co-expressed ribosomal
proteins, components of the 40S and 60S ribosomal sub-
units, were shown in Fig. 10. Interestingly, eukaryotic
initiation translation factor 5 (eIF5) involved in the
Figure 4 A: lipid content in adipocytes was quantified with Oil
Red O. Absorbance of extracted dye was measured at 500 nm.
Data are shown as mean ± SEM (n = 5). Different letters indicate
significant differences (p ≤ 0.05). B: superoxide dismutase (SOD)
activity in culture media. Different letters indicate significant
differences (p ≤ 0.05). Data shown are mean ± SEM (n = 5).
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of a functional 80S initiation complex was up-regulated
at the last time point (Fig. 5).
The increase of several protein folding heat shock pro-
teins and genes involved in protein degradation was evi-
dent during this period (Fig. 5 and 10). The components
of the 26S proteasome, ubiquitin and several enzymes
involved in the ubiquitin conjugation to target proteins
were up-regulated at day 15 and even more markedly at
the end of the study period. High levels of 26S protea-
some non-ATPase regulatory subunit 14 (POH1), were
observed at day 30 while up-regulation of lysosomal
proteases (cathepsins) was seen from day 15 (Fig. 5).
Discussion
Our transcriptomic analyses suggest, as expected, that
early salmon aSVF culture contains a number of cell
types, including vascular cells, macrophages and lym-
phocytes, in addition to preadipocytes. Similar cell com-
position of aSVF was reported in mammals [38]. The
gene expression profiles at days 1 and 4 implied reten-
tion of multipotency of aSVF cells during the early
Figure 5 Results of microarray analyses, selected genes with expression changes. Samples from days 1, 4, 7, 9, 15 and 30 (5 pooled flasks
per day) were compared to an equalised mixture from all time-points. Data are log-ER (expression ratios). Significantly up- and down-regulated
genes (p < 0.01, t-test, 12 spot replicates per gene) are highlighted with red and green scales. NS - not significant, ND - not detected.
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markers of osteo/chondrogenic, myogenic, immune and
vasculature cell lineages (Fig. 5) and increase in adipo-
genic markers indicate that the preadipocyte precursors,
probably due to their active proliferation, become the
preponderant cell type at confluence.
Recent studies in mammals showed that tissue-resi-
dent MSCs originate from the smooth-muscle-like peri-
cytes [39,40], which are laid over junctions of
endothelial cells in blood vessel walls [41]. Once liber-
ated from the endothelial cell, pericyte is activated and
can be considered a stem cell [42]. Characterisics of the
WAT population of stem cells and early events in the
determination phase are much less studied than the
terminal differentiation phase of adipogenesis. The
breakthrough in the understanding of elusive origins of
the adipogenic MSCs was made only recently in a study
of Tang et al. [9], which demonstrated that pericytes
surrounding blood vessel walls in WAT are precursor
cells of preadipocytes. Gradual attenuation of the vascu-
lature specific genes glomulin and LIVE1 and increase
of the pericytic marker TAGLN at days 7 and 9 support
perivascular origin of salmon preadipocytes as well.
Early PPARg expression could represent an additional
Figure 6 Immune genes analyzed with real-time qPCR. In this and other panels data are shown as -ΔΔCt ± SE (n = 5). Significant difference
from day 1 (t-test, p < 0.05) is indicated with *. TNFa - tumour necrosis factor alpha, TNF decoy - tumour necrosis factor decoy receptor, FLAP -
5-lipoxygenase-activating protein, JAK1 - janus kinase 1, PD-L1 - programmed cell death ligand 1, IL-13 a2 - interleukin 13, LECT2 - leukocyte cell-
derived chemotaxin a2, C5 - complement component 5.
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sors in our model since Tang et al. confirmed PPARg as
a specific marker of the perivascular fraction in subcon-
fluent aSVF [9]. Indeed, our finding of high levels of
PPARg mRNA well before confluence contradicts the
cell culture studies reviewed in [18] as the expression of
C/EBPb and C/EBPδ predate the expression of PPARg
and C/EBPa [17,18], which then activate adipocyte-spe-
cific genes during terminal differentiation. This illus-
trates the advantage of primary cell cultures, which offer
possibilities to gain valuable insight into the early mole-
cular events of adipogenic differentiation.
Commitment of multipotent MSCs to the adipogenic
lineage involves simultaneous inhibition of other
mesenchymal lineages. Starting from day 6 we observed
consistently decreased expression of MyoD, an early
marker of the myogenic lineage. MyoD regulates the cell
cycle in terminally differentiated myocytes by inducing
CDK inhibitor p21, which irreversibly arrests prolifera-
tion [43]. MyoD may play a similar role in mature adi-
pocytes and in theory this could account for the
increased expression at day 30. Activation of BMP4
from day 9 was an additional evidence for the inhibition
of myogenesis. This growth factor equally promotes dif-
ferentiation of the adipose, cartilage or bone lineages
depending on the culture conditions [44,45]. Therefore,
activation of BMP4 is necessary but not sufficient for
the commitment of preadipocytes. PPARg is a master
Figure 7 Cell lineage markers analyzed with real-time qPCR. PPARg - peroxisome proliferator-activated receptor g, MyoD - myogenic factor
D, BMP4 - bone morphogenic protein 4, 1C. C/EBP - CCAAT/enhancer-binding proteins a, b and δ, LPL - lipoprotein lipase, FAS - fatty acid
synthase.
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Page 8 of 17Figure 8 Genes for enzymes from different pathways of carbohydrate and lipid metabolism analyzed with real-time qPCR.H K-
hexokinase, G6PD - glucose-6-phosphate dehydrogenase, PFK - phosphofructokinase, PK - pyruvate kinase, MDHC - malate dehydrogenase,
PEPCKC - phosphoenolpyruvate carboxykinase C, PGD - 6- phosphogluconate dehydrogenase, TKT - transketolase, MTP - microsomal triglyceride
transfer protein, CD36 - cluster of differentiation 36, ATP binding - ATP-binding cassette transporter 2.
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myogenesis, osteogenesis and chondrogenesis [44,46,47].
Thus, high expression of PPARg observed long before
confluence with the peak at day 6 probably posed a bar-
rier to the induction of non-adipogenic mesenchymal
cell lineages. Non-adipogenic developmental pathways
are expected to be strongly suppressed by the addition
of hormones. Yet, we did not find any noticeable
changes in the markers of different cell types after day 9
and earliest increased level of the anti-osteogenic GAS6
was observed at day 15.
Our PCNA results suggested the highest proliferative
activity during the first days of culture followed by a
moderate reduction of mitotic activity at day 6 and
much greater decrease by day 30. Overall, the expres-
sion patterns of genes involved in cell cycle were in
concordance with these changes. Highest levels of the
key negative cell cycle regulators (e.g. RBL1, p53-like,
GADD45g) were observed during days 15-30. An addi-
tional evidence for the anti-proliferative status was the
up-regulation of several pro-apoptotic genes, including
retinoic acid-regulated apoptosis-related protein 3
(APR3). APR3 arrests cell cycle by suppressing the
activity of cyclin D1 [48], which was also induced at
the latest stage. Differentiation of adipocytes in mam-
mals is associated with a reduction in proliferation at
confluence followed by subsequent activation or clonal
expansion and eventually with cell cycle arrest at term-
inal differentiation [49]. Our results revealed the diver-
sity of mechanisms potentially employed in the
execution of the similar stage of events that occur dur-
ing Atlantic salmon adipogenesis. Given that WAT is a
highly specialized organ that functions to regulate
Figure 9 Genes for antioxidants and proteins involved in unfolded protein responses analyzed with real-time qPCR.P R D X 1-
peroxiredoxin 1, GPx2 - glutathione peroxidase 2, ATF6 - activating transcription factor 6, XBP1 - x-box binding protein 1, GRP78 - glucose-
regulated protein 78, 18S.
Figure 10 Ribosomal proteins analyzed with microarrays.D a t a
are mean log-(ER) ± SEM of twenty and ten genes involved in 60S
and 40S subunit assembly respectively.
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sensing mechanisms could be opted for a role in the
control of proliferation. Growth cycle arrest of salmon
adipocytes was in parallel with the up-regulation of the
fatty acid binding protein 3 (FABP3) that participates
in the uptake, intracellular metabolism and transport
of long chain fatty acids. FABP3 seems like a good
candidate that could be involved in this type of regula-
tion since its growth arrest activity was previously
demonstrated in mammalian epithelial cells [50].
Further, minimizing protein synthesis may also control
proliferation as cell cycle arrest is a well established
consequence of the general translational arrest, implied
from day 15 onwards.
Microarray analyses suggested changes in nutrient
metabolism in the late phase of adipogenesis (day 30).
As a consequence of the up-regulation of pyruvate dehy-
drogenase kinase that inactivates pyruvate dehydrogen-
ase, the Krebbs cycle most likely relied on the
preferential use of acetyl-CoA from FA oxidation rather
than pyruvate to cover the cellular energy requirements.
Also, the expression of genes involved in FA b-oxida-
tion, acyl-Coenzyme A dehydrogenase and acyl-Coen-
zyme A binding protein, steadily increased towards the
end of adipogenesis. The up-regulation of G6PD and
PGD pointed to the importance of the PPP, which gen-
erates NADPH required for accumulation of lipids. The
PPP can be seen as an alternative to glycolysis, because
in addition to generating NADPH and R5P, it can also
provide cells with G3P, the phosphorylated glycerol
backbone suitable for TAG synthesis. Induction of gly-
colytic PFK was also in line with the increased produc-
tion of G3P and TAG biosynthesis. Biosynthesis of
carbohydrates in carnivourous fish species could be
important due to the very low carbohydrate dietary level
in their natural diets [51]. Indeed, we have seen regula-
tions in all major glucose metabolic pathways in our
model (Fig. 8); however, differentiation of adipocytes did
not involve induction of HK, one of the key enzymes of
glucose metabolism that only showed slight up-regula-
tion at day 30. This indirectly suggested that the trans-
formation of gluconeogenic amino acids into glucose is
important in adipocytes of Atlantic salmon, at least in
vitro. In addition, late activity of two key glyceroneo-
genic genes, MDHC and PEPCKC implied that glycero-
neogenesis, which can be fed with mitochondrial
intermediates derived from lactate and gluconeogenic
amino acids, in addition to pyruvate, was active in devel-
oping fish adipocytes. To conclude, these findings illu-
minate potentially novel aspects of nutrient metabolism
in adipocytes, which might take advantage of the cou-
pling of glycolysis, the PPP and glyceroneogenesis, in
order to fulfil shifting demands for the three major pro-
ducts of these pathways: G3P, R5P and NADPH.
NADPH produced by PPP is also crucially important
for the cellular antioxidant defence since it is required
for the regeneration of oxidized glutathione by glu-
tathione reductase (GSR). Up-regulation of GSR and a
suite of genes involved in metabolism of glutathione,
thioredoxin and iron was a prominent feature of late
salmon adipocyte differentiation (days 15-30). Indeed, a
recently introduced concept [52-54,4] clearly demon-
strated ROS as anti-adipogenic molecules that inhibit
preadipocyte proliferation and differentiation. A reduced
redox state in WAT is now recognised as a distinct
characteristic of visceral obesity in mammals, with over-
expression of GPX peroxidases and high content of
hydrophilic antioxidant gluthathione associated with
pro-adipogenic processes. Induction of the number of
GPXs, known to be sensitive to lipid peroxidation,
implied ROS-provoked response in our culture and the
need to maintain highly reduced state of the intracellu-
lar environment. However, contrary to what could be
expected in situations of high ROS production, neither
gene expression nor activity of SOD increased. In fact,
the activity of this important ROS scavenger progres-
sively declined during adipocyte differentiation. Thus,
our data corroborated the indespensible role of glu-
tathione-based antioxidant system in the maintenance of
the reduced intracellular state in white adipocytes of
fish.
Accumulation of lipids in adipocytes coincided with
the activation of genes coding for secreted proteins,
such as adipokines adipsin and visfatin. Together with
the previous finding of leptin secretion by Atlantic sal-
mon adipocytes [10], this supports the notion of WAT
as an active endocrine organ in fish. Enhanced secretion
may impose an additional load on the ER actively
engaged in lipid droplet synthesis [55]. The ER compart-
ment is suspected to exert a great deal of control over
adipogenesis and association of obesity with ER-stress is
firmly established [56]. Up-regulation of XBP1 and
ATF6 at day 15 in salmon adipocytes implied activation
of UPR in response to perturbations in the ER homeos-
tasis [57]. Moreover, endoplasmic GRP78, which is
located downstream from ATF6 in the UPR signalling
cascade was down-regulated throughout the whole stu-
died period but increased in expression at day 30. A
number of changes that are typical of UPR [35] was a
hallmark of the latest stages of adipogenesis in our
model. UPR as a collection of pathways aimed at restor-
ing ER function may serve different adaptive roles and is
observed both under pathological and normal physiolo-
gical situations [58]; for example, it is part of the devel-
opmental program in highly specialized secretory B and
T cells [59] and ß-pancreatic cells [60]. The revealed
UPR in developing fish adipocytes appears as a highly
tailored homeostatic mechanism that is activated when
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capacity. Although ER is mainly considered to be a pro-
tein-folding factory, all proposed models of LD forma-
tion emphasize the engagement of the ER compartment
in the process [61].
UPR utilises two broad strategies to relieve stress in
the ER: increased clearance of misfolded proteins from
the ER and reduction of new protein influx into the ER.
We found ample evidence for the activation of the 26S
proteasome and autophagy-lysosomal proteolytic path-
ways, which degrade misfolded proteins. Components of
the membrane protein complex, derlin 1 and p97-inter-
acting cofactor p47, which mediate transport from the
ER lumen into the cytosol were induced at day 30, while
other proteolytic pathways were up-regulated even ear-
lier. UPR-induced proteolysis may be employed to initi-
ate the breakdown of superfluous proteins and
organelles that must be replaced by more highly specia-
lised cellular components during the adipocyte develop-
ment. Without a doubt, considerable remodelling of the
cellular architecture occurs during terminal differentia-
tion of Atlantic salmon adipocytes.
UPR also activates genes involved in protein folding.
Hsp40s and other J-domain-containing proteins act as
co-chaperones for Hsp70s helping to restore homeosta-
sis in the ER and in addition may have pro-degradation
roles. Down-regulation of translational machinery is
commonly observed during UPR [35], and in our study,
it involved a dramatic reduction in expression of riboso-
mal proteins.
Alteration of the ribosomal composition is most cer-
tainly involved in the multiple regulation of the ER-
stress response. The curious up-regulation of the 40S
subunit 18S rRNA through most of the terminal differ-
entiation against the majority of down-regulated riboso-
mal proteins is bound to have important consequences
given the high level of 18S constitutive expression. This
could signify a switch to a less efficient protein transla-
tion as increase in 18S negatively affects the ribosomal
subunit ratio that favours protein production [62]. On
the other side, reduced expression of 18S at the very
end of differentiation could improve the effectiveness of
protein synthesis in adipocytes that acquire secretory
phenotype. In conclusion, fully matured adipocytes seem
to reprogram the pattern of gene expression to sustain a
certain level of protein production, congruent with the
now recognised endocrine functions of WAT.
Secreted adipsin and visfatin have multiple immune
functions as most other adipokines [63]. Overall, expres-
sion changes of a large number of immune genes were
characteristic of Atlantic salmon aSVF culture. Dissimi-
lar temporary profiles suggest different regulatory and
physiological roles of these genes. Additionaly, high
initial levels and subsequent decrease of the chemokine
receptors, TNFa and a panel of TNF-related genes
could be explained by the changes in relative abundance
of non-adipogenic cells that possess pronounced
immune properties. In mammals, TNFa has high anti-
adipogenic activity [64], which was recently shown to be
conserved in fish [65]. Therefore, down-regulation of
the TNF axis at days 7-9 was probably important for the
onset of adipocyte differentiation. However, a number of
immune genes showed either stable increase since day 4
(complement component C5) or biphasic regulation
with the second activation after hormone induction
(LECT2). Highest expression levels of many genes with
diverse roles in different inflammatory pathways were
observed during terminal adipocyte differentiation.
Numerous independent studies have provided evidence
that a set of inflammatory and stress-response genes is
activated in obesity in mammals (reviewed in [66]).
Some of these genes likely have important roles in the
coordination of homeostasis in WAT, similar to the
established roles of TNFa in modulating proliferative
abilities in preadipocytes or metabolic activities in
mature adipocytes.
An intriguing example is a group of virus responsive
genes including TLR3, a receptor of double stranded
RNA and a group of galectins, previously not reported
to have roles in any aspect of adipocyte biology. The lat-
ter includes galectin 9, which showed highly specific
responses to viruses in previous studies from our group
[67,68]. However, a large portion of immune genes,
including complement component C5, JAK1, the key
actor of interferon signaling and FLAP, the regulator of
eicosanoid metabolism, decreased expression by the
time of AP1 establishment. Finally, our results do not
permit for major conclusions as to whether immune
genes are important for adipogenesis or change expres-
sion as a consequence of differentiation and/or stress
responses. However, it is clear that Atlantic salmon
WAT possesses high potential for immune activity.
It is tempting to explain the activation of immune
genes in differentiating adipocytes as a side effect of
adaptation to the oxidative and ER stress, since stress
and immune responses share common regulatory path-
ways. Ozcan et al. [56] showed that ER-stress-induced
JNK-AP1 axis is the central link between TAG overload
in liver and diabetes. Most interestingly, this is in agree-
ment with our study, which shows that the same players
are activated in fish adipocytes in response to increased
lipid deposition. Continuous administration of lipids led
to the maximal observed TAG loading at the end of the
studied period, when the collective and highest expres-
sion of the AP1 complex components, including all c-
Jun and JunB members was also observed. This addi-
tionally coincided with the induction of POH1, a regula-
tory subunit of the 26S proteasome that has a specific
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accumulation and subsequent increase in AP1-mediated
gene expression [66]. A suite of highly expressed
immune genes at this time supported an inflammatory
type reaction in adipocytes. Hence, an unrelieved ER-
stress could likely be the major cause of chronic inflam-
matory responses in lipid overloaded white adipocytes in
fish.
Conclusions
Our study revealed concordance between the gene
expression profiles and the key events during adipogenic
development of the primary culture of aSVF cells,
including fluctuations of proliferative activity, induction
of adipogenic differentiation and suppression of other
mesenchymal cell lineages and final tuning of metabo-
lism towards production and accumulation of lipids. For
the first time in a fish species we show that the estab-
lishment of mature adipocyte phenotype is associated
with high activity of immune genes, activated UPR and
responses to oxidative stress. These changes are likely to
be part of the normal adipocyte development but may
be accentuated when cells are overloaded with lipids.
High expression of pro-inflammatory mediators imply
that excessive growth of WAT in fish may cause dis-
turbed endocrine function with possible negative effects
on health, as seen in mammals.
Methods
Preadipocyte isolation and culture conditions
Atlantic salmon was reared at Nofima Marin station at
Averøy, Norway on a commercial diet to weight of 2-3
kg. Fish were anaesthetized with metacain (MS-222),
bled by cut of arch bows of the gills and killed by a
blow to the head. The experiment was conducted
according to the National Guidelines for Animal Care
and Welfare of the Norwegian Ministry of Research.
Visceral adipose tissue was excised and salmon preadi-
pocytes were isolated as described in Vegusdal et al.
[10]. Briefly, the dissected fat tissue was washed with
phosphate buffered saline (PBS, pH 7.4) (unless other-
wise stated, all chemicals were obtained from Sigma-
Aldrich Chemical Co., St. Louis, MO, USA), minced and
digested in 0.1% collagenase (type I) in HBSS (1 g tis-
sue/5 mL HBSS) at 13°C for 1 h under shaking and fil-
tered through 250 and 100 μm nylon. The resulting cell
suspension was then centrifuged at 700 × g for 10 min
at 10°C. The buoyant fat layer with mature adipocytes
was removed by aspiration, while the preadipocytes
were pelleted on the bottom. After washing twice, the
cells were resuspended in growth medium containing L-
15, 10% fetal bovine serum (FBS), 2 mM L glutamine,
10 mM HEPES, and antibiotics (mixture of penicillin,
streptomycin and amphotericin B) and seeded on
laminin coated cell-culture flasks at a density of
approximately 10 g tissue/25 cm
2. The cells were kept
at 13°C and media were changed every 3 days. Cells
reached confluence after approximately 1 week. Conflu-
ent cells were cultivated for 48 h in an differentiation
inducing medium, i.e. growth medium supplemented
with 1 μM dexamethasone, 33 μM biotin, 10 nM triio-
dothyronine, 17 μM panthothenate and 25 μM isobutyl-
methylxanthine, 20 μg/ml insulin and a lipid mixture (1
μl/ml; corresponding to 45 mg/ml cholesterol, 100 mg/
ml cod liver oil FA (methyl esters). After that cells were
transferred to a maintenance differentiation media con-
taining growth media only supplemented with 2 μl/ml
of lipid mixture. Media was changed every 3 days until
the cells reached the final differentiation stage with mor-
phology of mature adipocytes (day 30).
Electron microscopy
Cells for electron microscopy studies were taken from
cultures at days 15 and 30. Cells were washed in 0.1 M
PBS (pH 7.4), then fixed in 2% glutar aldehyde in 0.1 M
cacodylate buffer (pH 7.4) at 4°C for 24 h. The cells
were the harvested, rinsed in 0.1 M cacodylate buffer
and post-fixed for 60 min in 2% OsO4 containing 1.5%
potassium ferrocyanide, followed by en bloc staining
with 1.5% uranyl acetate. Cells were dehydrated in a ser-
ies of ethanol solutions (70%, 90%, 96%, and 100%) and
propylene oxide, and then embedded in epon resin,
which was polymerized at 60°C for 24 h. Ultrathin sec-
tions (approximately 50 nm) were cut on a Reichert
Ultracut E ultramicrotome using a diamond knife. The
sections were placed onto formvar/carbon-coated 75-
mesh copper grids, post-stained for 2 min with 0.2%
lead citrate solution in 0.1 M NaOH, and examined in a
Philips CM 100 transmission electron microscope at an
accelerating voltage of 80 kV.
Microarray analyses
The samples for microarrays analyses were taken at days
1, 4, 7, 9, 12 and 30. The salmonid fish microarray
(SFA2, immunochip) includes 1800 unique clones
printed each in six spot replicates. Total RNA was
extracted by using RNeasy® Mini Kit (Qiagen, Valencia,
CA, USA), according to the manufacturer’s instruction.
RNA was treated with RNase-free DNase I (Qiagen,
Valencia, CA, USA), to remove any contaminating
DNA. All RNA samples used in our experiments had
A260/280 ratios between 1.80 and 2.30. The total RNA
concentration was determined at 260 nm using spectro-
photometry. Equal inputs from 5 cell flask replicates
were pooled for each time point. Equalised control was
made by mixing RNA from each time point. The test
and control samples (15 μg RNA in each) were labelled
with respectively Cy5-dUTP and Cy3-dUTP (Amersham
Pharmacia, Little Chalfont, UK). The fluorescent dyes
were incorporated in cDNA using the SuperScript™
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CA, USA). The cDNA synthesis was performed at 46°C
for 3 h in a 20 μl reaction volume, following RNA
degradation with 0.2 M NaOH at 37°C for 15 min and
alkaline neutralization with 0.6 M Hepes. Labelled
cDNA was purified with Microcon YM30 (Millipore,
Bedford, MA, USA). The slides were pretreated with 1%
BSA fraction V, 5 × SSC, 0.1% SDS (30 min at 50°C)
a n dw a s h e dw i t h2×S S C( 3m i n )a n d0 . 2×S S C( 3
min) and hybridized overnight at 60°C in a cocktail con-
taining 1.3 × Denhardt’s, 3 × SSC 0.3% SDS, 0.67 μg/μl
polyadenylate and 1.4 μg/μly e a s tt R N A .A f t e r
hybridization slides were washed at room temperature
in 0.5 × SSC and 0.1% SDS (15 min), 0.5 × SSC and
0.01% SDS (15 min), and twice in 0.06 × SSC (2 and 1
min, respectively). Scanning was performed with Axon
GenePix 4100A and images were processed with Gene-
Pix 6.0 (Molecular Devices,S u n n y v a l e ,C A ,U S A ) .T h e
spots were filtered by criterion (I-B)/(SI+SB) ≥ 0.6,
where I and B are the mean signal and background
intensities and SI, SB are the standard deviations. Low
quality spots were excluded from analysis and genes
presented with less than three high quality spots on a
slide were discarded. After subtraction of median
Table 1 Primers used for real-time qPCR analyses
Gene Forward primer (5’-3’) Reverse primer (5’-3’) Accession
number
Tumor necrosis factor alpha (TNFa) AGGTTGGCTATGGAGGCTGT TCTGCTTCAATGTATGGTGGG AF321836
Tumor necrosis factor (TNF) decoy TCTCCTGGTATTTGCGCTCTGTGGT TATAAGTCGGTGTGTGAGCGCCTGA CA351440
Arachidonate 5-lipoxygenase-activating protein
(FLAP)
TCTGAGTCATGCTGTCCGTAGTGGT CCTCCCTCTCTACCTTCGTTGCAAA CA369467
Tyrosine-protein kinase 1 (Jak1) GAGGAGTTTGTCCAGTTCGGTCCGT CATGCACCAGCTTCTTATCCTCCAG CA368994
Programmed death ligand 1 (PD-L1) TCAACGACTCTGGGGTGTACCGATG TCCACCTCATCTCCACCACGTCTC CA366631
Interleukin 13 receptor alpha 2 (IL13Ra2) TCTCTGAGCCGCTCAACCTGTCAT CGTTCCACGACAGCTTTATACGGA CA348044
Leukocyte cell-derived chemotaxin 2 (LECT2) CTGTGTTGTCAGAGTGCGAGATGGT TACACACAATGTCCAGGCCCTGA EXOB2
Complement component 5 (C5) AGAACTCTTCCGAGTTGGCATGGT AGTGATGCTGGGATCCATCTCTGA CA364804
Proliferator-activated receptor gamma (PPARg) CGTGTATCAAGACGCCAGCT TTGCAGCCCTCACAGACATG EU655708
Bone morphogenic protein 4 (BMP4) TCAAGTTGCCCATAGTCAGT CACCTGAACTCTACCAACCA FJ195610
Myogenic factor D (MyoD) CCGCAACACGAAGCAACTATTACAGC GGAACCCTCCTGGCCTGATAACAC AJ557150
CCAAT-enhancer-binding protein beta (C/EBPb) CAAACTACATTACCAGGC GTTATGTGTTGCCAGTTG EU668996
CCAAT-enhancer-binding protein delta (C/EBPδ) TTGGGCGGTGGAGCCTAT TTTCCTCGCCCGTGTCAT EU668997
CCAAT-enhancer-binding protein alpha (C/EBPa) AGACCTCGGCGAGATTTGT TGTGGAATAGATCAGCCAGGAA EU668995
Hexokinase (HK) GCTGAAGACCAGAGGCATCTTTGA GCTGCATACCTCCTTGACGATGAT AY864082
Glucose-6-phosphate dehydrogenase (G6PD) TGGTGCAGAACCTCATGGTCCTCA ATCCCGGATGATTCCAAAGTCGTC BT044902
Phosphofructokinase (PFK) AATCCATCGGCGTTCTGACAAGC GCCCGTACAGCAGCATTCATACCTT BT059256
Pyruvate kinase (PK) TGCCTTCATTCAGACGCAGCA CAGATGATTCCGGTGTTGCGA BT043851
Malate dehydrogenase cytoplasmic (MDHC) AGACGTCCACCACTGCAAGGTCAA TTAACAGCGTCGAAGCAGGCCA BT043497
Cytosolic phosphoenolpyruvate carboxykinase
(PEPCKC)
AGGGCATGGACCAGGAACTCC GGGCTCTCCATCCTGGGATGT BT072418
6-phosphogluconate dehydrogenase (PGD) CCAATGAGGCTAAAGGCACCAAGA CCAGCTTGTCGATGAAGTCATCCA BT050391
Transketolase (TKT) TGCCATCTCCGAGAGCAACATC CCGTGGGAATGGCTCTGAACAT BT059642
Peroxiredoxin 1 (PRDX1) CACTGCTGTGGTGGATGGACAGTT CCAGCGGGTAGAAGAAGAACACCA est02b08
Glutathione peroxidase 2 (GPX2) TGTACCTCAAGGAGAAGCTGCCGT ATTAAGGCCATGGGATCGTCGC est04e05
Activating transcription factor 6 (ATF6) CTCACACCATCAAAGCTACAGCGA GTGTCGCCTCGTCGATTTAACTCA CA367172
X-box binding protein 1 (XBP1) CGACTCAAATTCGACAACTGGGC TTTCTGTCTCTGGCTGTCTGGGCT CA385697
Microsomal triglyceride transfer protein (MTP) CAAAGACCAGCGTCAACAACAA CGCCTCTGTCTCAAAGCTCACT CA042356
78 kDa glucose-regulated protein (GRP78) GTGCAGCATGACATCAAGTA CTCTTCTTCTCGATAACCTT CA368961
Cluster of differentiation 36 (CD36) GGATGAACTCCCTGCATGTGA TGAGGCCAAAGTACTCGTCGA AY606034
ATP-binding cassette transporter 2 AGCGGGGGAAACAGTAGCAGGA GCCTGGTCTTGAGATTGTGGGTGT CA343913
Lipoprotein lipase (LPL) TGCTGGTAGCGGAGAAAGACAT CTGACCACCAGGAAGACACCAT BI468076
Fatty acid(FAS) TGCCTCAGCACCCTACTCTG GCTTTACAACCTCAGGATTGGC BT048827
18S TGTGCCGCTAGAGGTGAAATT GCAAATGCTTTCGCTTTCG AJ427629
Elongation factor 1A (EF1A) TGCCCCTCCAGGATGTCTAC CACGGCCCACAGGTACTG BG933853
Eukaryotic translation initiation factor 3 subunit 6 GTCGCCGTACCAGCAGGTGATT CGTGGGCCATCTTCTTCTCGA CX040383
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sion ratios were calculated. Lowess normalization was
p e r f o r m e df i r s tf o rt h ew h o l es l i d ea n dn e x tf o rt w e l v e
rows and four columns per slide. The differential
expression was assessed by difference of the mean log-
expression ratios between the slides with reverse label-
ling (6 spot replicates per gene on each slide, Student’s
t-test, p < 0.01). Complete microarray results are sub-
mitted to NCBI GEO Omnibus (GSE18389).
Quantitative real-time RT-PCR
RNA isolated at days 1, 4, 5, 6, 7, 9, 10, 11, 12, 15, 20,
23 and 30 was used for qPCR. Approximately 200 ng of
total RNA was reverse-transcribed into cDNA using
TaqMan® Gold RT-PCR Kit (Applied Biosystems, Foster
C i t y ,C A ,U S A ) ,a2 5μl reaction system according to
the manufacturer’s protocol. The PCR primers (Table 1)
were designed using the Vector NTI (Invitrogen, Carls-
bad, CA, USA) and synthesized by Invitrogen. Efficiency
was checked from tenfold serial dilutions of cDNA for
each primer pair. A 2 × SYBR® Green PCR Mastermix
(Roche Diagnostics, Mannheim, Germany), 0.4 μMo f
each primer, and the cDNA template were mixed in 12
μl volumes. PCR was performed in duplicates in 96-well
optical plates on Light Cycler 480 (Roche Diagnostics,
Mannheim, Germany). Different controls were used for
microarray and qPCR. All time points were compared
relative to day 1 in qPCR analyses. Relative expression
of mRNA was calculated using the ΔΔCt method. Three
commonly used genes (18S, elongation factor 1A and
eukaryotic translation initiation factor 3, subunit 6) were
tested for stability using the GeNorm and NormFinder.
Finally, elongation factor 1A (EF1A) met criteria of sta-
bility in the analyzed material. Differences between con-
trol and cells at different developmental stages were
assessed with Student’s t-test (p < 0.05).
Cell proliferation
Cell proliferation was assessed by the immunocytochem-
ical detection of PCNA)(Zymed Laboratories, South San
Francisco, CA, USA). Cells were washed in PBS and
fixed in 70% ethanol for 30 minutes at 4°C. Endogenous
peroxidise activity was blocked with with 3% hydrogen
peroxide in methanol for 10 min. The cells were washed
three times with in PBS, then incubated with a mouse
anti PCNA monoclonal antibody (clone PC10) using a
PCNA immuno detection kit, following the manufac-
turer’s instructions. The cells were counterstained with
Mayer’s haematoxylin for 2 min, washed in water, dehy-
drated in a graded series of alcohol solutions, cleared
with xylene, and mounted with Histomount. PCNA-con-
taining nuclei were stained dark brown. Two hundred
cells were observed and the percentage of proliferating
cell was calculated.
Lipid accumulation in adipocytes
The quantity of lipids in cytoplasm were estimated by
oil-red O staining according to Ramirez-Zacarias et al.
[70] on days 1, 4, 7, 9, 15 and 30. Briefly, cells were
washed twice with PBS, fixed with 10% cold formalin
for 30 min, rinsed in water and stained for 2 h with fil-
tered oil red O in isopropanol at room temperature. For
relative quantitative measurements of TAGs accumula-
tion, bottles were washed with PBS to remove excess of
stain solution, dried, the colour was dissolved in 100%
isopropanol and the absorbance was measured spectro-
photometrically in a Victor 3 microplate reader Perki-
nElmer (Wellesley, MA, USA) at 500 nm.
Superoxide dismutase assay
SOD activity was assayed with a kit (Cayman Chemicals,
Ann Arbor, MI, USA), which utilizes a tetrazolium salt
to detect superoxide radicals generated by xanthine oxi-
dase and hypoxanthine. Colour was measured at 405
nm in a Titertek Multiskan PLUS MKII (Labsystems,
Helsinki, Finland) plate reader. One unit of SOD was
defined as the amount of enzyme needed to achieve
50% dismutation of the superoxide radical.
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